Nose | |||||
---|---|---|---|---|---|
Nose / Nasal congestion | |||||
ephedrine hydrochloride | NON-FORMULARY | ||||
NHSE OTC coughs and cold
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Solution for injection | |||||
Ephedrine hydrochloride (Non-proprietary) | NON-FORMULARY | ||||
pseudoephedrine hydrochloride | NON-FORMULARY | ||||
NHSE OTC coughs and cold
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Oral solution | |||||
Galpseud (Thornton & Ross Ltd) | NON-FORMULARY | ||||
NHSE OTC coughs and cold
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Sudafed Non-Drowsy Decongestant (McNeil Products Ltd) | NON-FORMULARY | ||||
NHSE OTC coughs and cold
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
xylometazoline hydrochloride | NON-FORMULARY | ||||
NHSE OTC coughs and cold
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Spray | |||||
Otrivine (Haleon UK Ltd) | NON-FORMULARY | ||||
NHSE OTC coughs and cold
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Sudafed Non-Drowsy Decongestant (McNeil Products Ltd) | NON-FORMULARY | ||||
NHSE OTC coughs and cold
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Nasal drops | |||||
Otrivine (Haleon UK Ltd) | NON-FORMULARY | ||||
NHSE OTC coughs and cold
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Nose / Nasal infection | |||||
mupirocin | FORMULARY PRODUCT | ||||
Nasal ointment | |||||
Bactroban (GlaxoSmithKline UK Ltd) | FORMULARY PRODUCT | ||||
Nose / Nasal inflammation, nasal polyps and rhinitis | |||||
azelastine hydrochloride | FORMULARY PRODUCT | ||||
NHS England OTC nasal sprays
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Eye drops | |||||
Optilast (Viatris UK Healthcare Ltd) | NON-FORMULARY | ||||
Spray | |||||
Rhinolast (Viatris UK Healthcare Ltd) | FORMULARY PRODUCT | ||||
NHS England OTC nasal sprays
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
beclometasone dipropionate | NON-FORMULARY | ||||
NHS England OTC nasal sprays
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Spray | |||||
Beclometasone dipropionate (Non-proprietary) | NON-FORMULARY | ||||
NHS England OTC nasal sprays
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Beconase (GlaxoSmithKline UK Ltd, Omega Pharma Ltd) | NON-FORMULARY | ||||
NHS England OTC nasal sprays
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Nasobec (Teva UK Ltd) | NON-FORMULARY | ||||
NHS England OTC nasal sprays
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
betamethasone | FORMULARY PRODUCT | ||||
budesonide | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |
NICE TA708 |
|||
NHS England OTC nasal sprays
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Spray | |||||
Budesonide (Non-proprietary) | NON-FORMULARY | ||||
NHS England OTC nasal sprays
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
fluticasone | FORMULARY PRODUCT | ||||
NHS England OTC nasal sprays
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Spray | |||||
Fluticasone (Non-proprietary) | FORMULARY PRODUCT | ||||
NHS England OTC nasal sprays
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Avamys (GlaxoSmithKline UK Ltd) | NON-FORMULARY | ||||
Flixonase (GlaxoSmithKline UK Ltd, Haleon UK Ltd) | FORMULARY PRODUCT | ||||
NHS England OTC nasal sprays
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Nasofan (Teva UK Ltd) | NON-FORMULARY | ||||
fluticasone with azelastine | FORMULARY PRODUCT | ||||
Allergic Rhinitis
The following guidelines are available on the Practice Portal: |
|||||
Spray | |||||
Dymista (Viatris UK Healthcare Ltd) | FORMULARY PRODUCT | ||||
ipratropium bromide | FORMULARY PRODUCT | ||||
Spray | |||||
Rinatec (Sanofi Consumer Healthcare) | FORMULARY PRODUCT | ||||
mometasone furoate | FORMULARY PRODUCT | ||||
Spray | |||||
Mometasone furoate (Non-proprietary) | FORMULARY PRODUCT | ||||
Nasonex (Organon Pharma (UK) Ltd) | NON-FORMULARY | ||||
triamcinolone acetonide | NON-FORMULARY | ||||
Suspension for injection | |||||
Adcortyl Intra-articular / Intradermal (Bristol-Myers Squibb Pharmaceuticals Ltd) | NON-FORMULARY | ||||
Spray | |||||
Nasacort (Sanofi Consumer Healthcare) | NON-FORMULARY |